217 Publications (Page 1 of 9)
2021
Impact of smoke-free ordinance strength on smoking prevalence and lung cancer incidenceNguyen, Ryan H⋅Nguyen, R.H.⋅Nguyen, Ryan H⋅Vater, L.B.⋅Vater, Laura B⋅Vater, Laura B⋅Timsina, L.R.⋅Timsina, Lava R⋅Timsina, Lava R⋅Durm, Gregory A⋅Durm, Gregory A⋅Durm, G.A.⋅Rupp, K.⋅Rupp, Katelin⋅Rupp, Katelin⋅Wright, Keylee⋅Wright, Keylee⋅Wright, K.⋅Spitznagle, M.H.⋅Spitznagle, Miranda H⋅Spitznagle, Miranda H⋅Brandy, Paul⋅Brandy, Paul⋅Paul, B.⋅Jalal, Shadia I⋅Jalal, S.I.⋅Jalal, Shadia I⋅Carter-Harris, Lisa⋅Carter-Harris, Lisa⋅Carter-Harris, L.⋅Hudmon, Karen S⋅Hudmon, K.S.⋅Hudmon, Karen S⋅Hanna, Nasser H⋅Hanna, Nasser H⋅Hanna, N.H.⋅Loehrer, Patrick J⋅Loehrer, P.J.⋅Loehrer, Patrick J⋅Ceppa, D.P.⋅Ceppa, DuyKhanh P and Ceppa, DuyKhanh PPLoS One, vol. 16, (no. 4), Apr 2021.
| Journal Article
Phase II trial of brentuximab vedotin in relapsed/refractory germ cell tumorsAshkar, Ryan⋅Ashkar, Ryan⋅Ashkar, Ryan⋅Ashkar, Ryan⋅Feldman, Darren R⋅Feldman, Darren R⋅Feldman, Darren R⋅Feldman, Darren R⋅⋅Adra, Nabil⋅Adra, Nabil⋅⋅Zaid, Mohammad Abu⋅Zaid, Mohammad A⋅Zaid, Mohammad Abu⋅Zaid, Mohammad A⋅Funt, Samuel A⋅Funt, Samuel A⋅Funt, Samuel A⋅Funt, Samuel A⋅Althouse, Sandra K⋅Althouse, Sandra K⋅Althouse, Sandra K⋅Althouse, Sandra K⋅Perkins, Susan M⋅Perkins, Susan M⋅Perkins, Susan M⋅Perkins, Susan M⋅Snow, Christin I⋅Snow, Christin I⋅Snow, Christin I⋅Snow, Christin I⋅Lazzara, Kayla M⋅Lazzara, Kayla M⋅Lazzara, Kayla M⋅Lazzara, Kayla M⋅Sego, Lina M⋅Sego, Lina M⋅Sego, Lina M⋅Sego, Lina M⋅Quinn, David I⋅Quinn, David I⋅Quinn, David I⋅Quinn, David I⋅Hanna, Nasser H⋅Hanna, Nasser H⋅Hanna, Nasser H⋅Hanna, Nasser H⋅Einhorn, Lawrence H⋅Einhorn, Lawrence H⋅Einhorn, Lawrence H⋅Einhorn, Lawrence H⋅Albany, Costantine⋅Costantine, Albany⋅Albany, Costantine and Costantine, AlbanyInvestigational New Drugs, vol. 39, (no. 6), pp. 1656-1663, Dec 2021.
| Journal Article
2020
A phase 2 trial of consolidation pembrolizumab following concurrent chemoradiation for patients with unresectable stage III non–small cell lung cancer: Hoosier Cancer Research Network LUN 14‐179Durm, Greg A⋅Durm, Greg A⋅Durm, Greg A⋅Durm, Greg A⋅Durm, Greg A⋅Jabbour, Salma K⋅Jabbour, Salma K⋅Jabbour, Salma K⋅Jabbour, Salma K⋅Jabbour, Salma K⋅Althouse, Sandra K⋅Althouse, Sandra K⋅Althouse, Sandra K⋅Althouse, Sandra K⋅Althouse, Sandra K⋅Liu, Ziyue⋅Liu, Ziyue⋅Liu, Ziyue⋅Liu, Ziyue⋅Liu, Ziyue⋅Sadiq, Ahad A⋅Sadiq, Ahad A⋅Sadiq, Ahad A⋅Sadiq, Ahad A⋅Sadiq, Ahad A⋅Zon, Robin T⋅Zon, Robin T⋅Zon, Robin T⋅Zon, Robin T⋅Zon, Robin T⋅Jalal, Shadia I⋅Jalal, Shadia I⋅Jalal, Shadia I⋅Jalal, Shadia I⋅Jalal, Shadia I⋅Kloecker, Goetz H⋅Kloecker, Goetz H⋅Kloecker, Goetz H⋅Kloecker, Goetz H⋅Kloecker, Goetz H⋅Williamson, Michael J⋅Williamson, Michael J⋅Williamson, Michael J⋅Williamson, Michael J⋅Williamson, Michael J⋅Reckamp, Karen L⋅Reckamp, Karen L⋅Reckamp, Karen L⋅Reckamp, Karen L⋅Reckamp, Karen L⋅Langdon, Robert M⋅Langdon, Robert M⋅Langdon, Robert M⋅Langdon, Robert M⋅Langdon, Robert M⋅Kio, Ebenezer A⋅Kio, Ebenezer A⋅Kio, Ebenezer A⋅Kio, Ebenezer A⋅Kio, Ebenezer A⋅Gentzler, Ryan D⋅Gentzler, Ryan D⋅Gentzler, Ryan D⋅Gentzler, Ryan D⋅Gentzler, Ryan D⋅Adesunloye, Bamidele A⋅Adesunloye, Bamidele A⋅Adesunloye, Bamidele A⋅Adesunloye, Bamidele A⋅Adesunloye, Bamidele A⋅Harb, Wael A⋅Harb, Wael A⋅Harb, Wael A⋅Harb, Wael A⋅Harb, Wael A⋅Walling, Radhika V⋅Walling, Radhika V⋅Walling, Radhika V⋅Walling, Radhika V⋅Walling, Radhika V⋅Titzer, Michael L⋅Titzer, Michael L⋅Titzer, Michael L⋅Titzer, Michael L⋅Titzer, Michael L⋅Hanna, Nasser H⋅Hanna, Nasser H⋅Hanna, Nasser H⋅Hanna, Nasser H and Hanna, Nasser HCancer, vol. 126, (no. 19), pp. 4353-4361, Oct 2020.
| Journal Article
A phase II study assessing the safety and efficacy of ASP1650 in male patients with incurable platinum refractory germ cell tumorsAdra, Nabil⋅Adra, Nabil⋅Adra, Nabil⋅Vaughn, David J⋅Vaughn, David J⋅Vaughn, David J⋅Einhorn, Lawrence⋅Einhorn, Lawrence⋅Einhorn, Lawrence⋅Hanna, Nasser H⋅Hanna, Nasser H⋅Hanna, Nasser H⋅Rosales, Matt⋅Rosales, Matt⋅Rosales, Matt⋅Arozullah, Ahsan⋅Arozullah, Ahsan⋅Arozullah, Ahsan⋅Feldman, Darren R⋅Feldman, Darren R and Feldman, Darren RJournal of Clinical Oncology, vol. 38, (no. 6_suppl), pp. TPS424, 2020-02-20.
| Journal Article
A phase I study of guadecitabine (SGI-110) plus cisplatin in patients with platinum refractory germ cell tumorsAlbany, Costantine⋅Albany, Costantine⋅Albany, Costantine⋅Spinella, Michael J⋅Spinella, Michael J⋅Spinella, Michael J⋅Adra, Nabil⋅Adra, Nabil⋅Adra, Nabil⋅Hanna, Nasser H⋅Hanna, Nasser H⋅Hanna, Nasser H⋅Einhorn, Lawrence⋅Einhorn, Lawrence and Einhorn, LawrenceJournal of Clinical Oncology, vol. 38, (no. 6_suppl), pp. 408, 2020-02-20.
| Journal Article
Computer-Tailored Decision Support Tool for Lung Cancer Screening: Community-Based Pilot Randomized Controlled Trial
Carter-Harris, Lisa⋅Comer, Robert S⋅Slaven, James E⋅Monahan, Patrick O⋅Vode, Emilee⋅Hanna, Nasser H⋅Ceppa, DuyKhanh P and Rawl, Susan M
Journal of Medical Internet Research, vol. 22, (no. 11), Nov 2020. | Journal Article
High‐dose chemotherapy plus peripheral blood stem cell transplantation for patients with relapsed germ cell tumors and active brain metastasesKalra, Maitri⋅Kalra, Maitri⋅Kalra, Maitri⋅Kalra, Maitri⋅Adra, Nabil⋅Adra, Nabil⋅Adra, Nabil⋅Adra, Nabil⋅Hanna, Nasser⋅Hanna, Nasser⋅Hanna, Nasser⋅Hanna, Nasser⋅Abonour, Rafat⋅Abonour, Rafat⋅Abonour, Rafat⋅Abonour, Rafat⋅Einhorn, Lawrence H⋅Einhorn, Lawrence H⋅Einhorn, Lawrence H and Einhorn, Lawrence HCancer, vol. 126, (no. 6), pp. 1202-1207, Mar 2020.
| Journal Article
Lung Cancer Screening Knowledge Among Internal Medicine Residents in a University Program
Urrutia Argueta, Samuel and Hanna, Nasser
Journal of cancer education : the official journal of the American Association for Cancer Education, 2020-Apr-19. | Journal Article
Practical challenges in patients with stage III NSCLC receiving checkpoint inhibitors after chemoradiation
Shukla, Nikhil A and Hanna, Nasser H
Lung Cancer Management, vol. 9, (no. 1), pp. LMT23, 20200201. | Journal Article
Prognostic significance of rate of tumor marker (TM) decline during high-dose chemotherapy (HDCT) for relapsed germ cell tumors (rGCT)Adra, Nabil⋅Adra, Nabil⋅Adra, Nabil⋅Adra, Nabil⋅Adra, Nabil⋅Althouse, Sandra K⋅Althouse, Sandra K⋅Althouse, Sandra K⋅Althouse, Sandra K⋅Althouse, Sandra K⋅Abonour, Rafat⋅Abonour, Rafat⋅Abonour, Rafat⋅Abonour, Rafat⋅Abonour, Rafat⋅Abu Zaid, Mohammad Issam⋅Abu Zaid, Mohammad Issam⋅Abu Zaid, Mohammad Issam⋅Abu Zaid, Mohammad Issam⋅Abu Zaid, Mohammad Issam⋅Liu, Hao⋅Liu, Hao⋅Liu, Hao⋅Liu, Hao⋅Liu, Hao⋅Hanna, Nasser H⋅Hanna, Nasser H⋅Hanna, Nasser H⋅Hanna, Nasser H⋅Hanna, Nasser H⋅Einhorn, Lawrence⋅Einhorn, Lawrence⋅Einhorn, Lawrence⋅Einhorn, Lawrence and Einhorn, LawrenceJournal of Clinical Oncology, vol. 38, (no. 6_suppl), pp. 403, 2020-02-20.
| Journal Article
Prognostic Value of Teratoma in Primary Tumor and Postchemotherapy Retroperitoneal Lymph Node Dissection Specimens in Patients With Metastatic Germ Cell TumorTaza, Fadi⋅Taza, Fadi⋅Taza, Fadi⋅Taza, Fadi⋅Taza, Fadi⋅Taza, Fadi⋅Chovanec, Michal⋅Chovanec, Michal⋅Chovanec, Michal⋅Chovanec, Michal⋅Chovanec, Michal⋅Chovanec, Michal⋅Snavely, Anna⋅Snavely, Anna⋅Snavely, Anna⋅Snavely, Anna⋅Snavely, Anna⋅Snavely, Anna⋅Hanna, Nasser H⋅Hanna, Nasser H⋅Hanna, Nasser H⋅Hanna, Nasser H⋅Hanna, Nasser H⋅Hanna, Nasser H⋅Cary, Clint⋅Cary, Clint⋅Cary, Clint⋅Cary, Clint⋅Cary, Clint⋅Cary, Clint⋅Masterson, Timothy A⋅Masterson, Timothy A⋅Masterson, Timothy A⋅Masterson, Timothy A⋅Masterson, Timothy A⋅Masterson, Timothy A⋅Foster, Richard S⋅Foster, Richard S⋅Foster, Richard S⋅Foster, Richard S⋅Foster, Richard S⋅Foster, Richard S⋅Einhorn, Lawrence H⋅Einhorn, Lawrence H⋅Einhorn, Lawrence H⋅Einhorn, Lawrence H⋅Einhorn, Lawrence H⋅Einhorn, Lawrence H⋅Albany, Costantine⋅Albany, Costantine⋅Albany, Costantine⋅Albany, Costantine⋅Albany, Costantine⋅Albany, Costantine⋅Adra, Nabil⋅Adra, Nabil⋅Adra, Nabil⋅Adra, Nabil⋅Adra, Nabil and Adra, NabilJournal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 38, (no. 12), pp. 1345, 2020-Apr-20.
| Journal Article
Prognostic Variables Associated With Improved Outcomes in Patients With Stage III NSCLC Treated With Chemoradiation Followed by Consolidation Pembrolizumab: A Subset Analysis of a Phase II Study From the Hoosier Cancer Research Network LUN 14-179Anouti, Bilal⋅Anouti, Bilal⋅Althouse, Sandra⋅Althouse, Sandra⋅Durm, Greg⋅Durm, Greg⋅Hanna, Nasser and Hanna, NasserClinical Lung Cancer, vol. 21, (no. 3), pp. 293, May 2020.
| Journal Article
Radiosurgery Dose Reduction for Brain Metastases on Immunotherapy (RADREMI): A Prospective Phase I Study ProtocolMcClelland, Shearwood⋅McClelland, Shearwood⋅Mc Clelland, Shearwood⋅McClelland, Shearwood⋅McClelland, Shearwood⋅McClelland, Shearwood⋅Lautenschlaeger, Tim⋅Lautenschlaeger, Tim⋅Lautenschlaeger, Tim⋅Lautenschlaeger, Tim⋅Lautenschlaeger, Tim⋅Lautenschlaeger, Tim⋅Zang, Yong⋅Zang, Yong⋅Zang, Yong⋅Zang, Yong⋅Zang, Yong⋅Zang, Yong⋅Hanna, Nasser H⋅Hanna, Nasser H⋅Hanna, Nasser H⋅Hanna, Nasser H⋅Hanna, Nasser H⋅Hanna, Nasser H⋅Shiue, Kevin⋅Shiue, Kevin⋅Shiue, Kevin⋅Shiue, Kevin⋅Shiue, Kevin⋅Shiue, Kevin⋅Kamer, Aaron P⋅Kamer, Aaron P⋅Kamer, Aaron P⋅Kamer, Aaron P⋅Kamer, Aaron P⋅Kamer, Aaron P⋅Agrawal, Namita⋅Agrawal, Namita⋅Agrawal, Namita⋅Agrawal, Namita⋅Agrawal, Namita⋅Agrawal, Namita⋅Ellsworth, Susannah G⋅Ellsworth, Susannah G⋅Ellsworth, Susannah G⋅Ellsworth, Susannah G⋅Ellsworth, Susannah G⋅Ellsworth, Susannah G⋅Rhome, Ryan M⋅Rhome, Ryan M⋅Rhome, Ryan M⋅Rhome, Ryan M⋅Rhome, Ryan M⋅Rhome, Ryan M⋅Watson, Gordon A⋅Watson, Gordon A⋅Watson, Gordon A⋅Watson, Gordon A⋅Watson, Gordon A and Watson, Gordon AReports of Practical Oncology & Radiotherapy, 2020-04-00.
| Journal Article
Risk Factors for Acute Kidney Injury During High-dose Chemotherapy and Outcomes for Patients With Relapsed Germ Cell TumorsZhang, Kevin Juan⋅Zhang, Kevin Juan⋅Zhang, Kevin Juan⋅Zhang, Kevin Juan⋅Zhang, Kevin Juan⋅Hanna, Nasser H⋅Hanna, Nasser H⋅Hanna, Nasser H⋅Hanna, Nasser H⋅Hanna, Nasser H⋅Althouse, Sandra K⋅Althouse, Sandra K⋅Althouse, Sandra K⋅Althouse, Sandra K⋅Althouse, Sandra K⋅Zaid, Mohammad Abu⋅Zaid, Mohammad Abu⋅Zaid, Mohammad Abu⋅Zaid, Mohammad Abu⋅Zaid, Mohammad Abu⋅Abonour, Rafat⋅Abonour, Rafat⋅Abonour, Rafat⋅Abonour, Rafat⋅Abonour, Rafat⋅Albany, Costantine⋅Albany, Costantine⋅Albany, Costantine⋅Albany, Costantine⋅Albany, Costantine⋅Einhorn, Lawrence H⋅Einhorn, Lawrence H⋅Einhorn, Lawrence H⋅Einhorn, Lawrence H⋅Einhorn, Lawrence H⋅Adra, Nabil⋅Adra, Nabil⋅Adra, Nabil⋅Adra, Nabil and Adra, NabilClinical Genitourinary Cancer, 2020-Feb-08.
| Journal Article
The Case for Maintenance Pemetrexed Plus BevacizumabHanna, Nasser⋅Hanna, Nasser⋅Jalal, Shadia and Jalal, ShadiaJournal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 38, (no. 7), pp. 771, 2020-Mar-01.
| Journal Article
Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO and OH (CCO) Joint Guideline UpdateHanna, Nasser H⋅Hanna, Nasser H⋅Schneider, Bryan J⋅Schneider, Bryan J⋅Temin, Sarah⋅Temin, Sarah⋅Baker, Jr, Sherman⋅Baker, Jr, Sherman⋅Brahmer, Julie⋅Brahmer, Julie⋅Ellis, Peter M⋅Ellis, Peter M⋅Gaspar, Laurie E⋅Gaspar, Laurie E⋅Haddad, Rami Y⋅Haddad, Rami Y⋅Hesketh, Paul J⋅Hesketh, Paul J⋅Jain, Dharamvir⋅Jain, Dharamvir⋅Jaiyesimi, Ishmael⋅Jaiyesimi, Ishmael⋅Johnson, David H⋅Johnson, David H⋅Leighl, Natasha B⋅Leighl, Natasha B⋅Phillips, Tanyanika⋅Phillips, Tanyanika⋅Riely, Gregory J⋅Riely, Gregory J⋅Robinson, Andrew G⋅Robinson, Andrew G⋅Rosell, Rafael⋅Rosell, Rafael⋅Schiller, Joan H⋅Schiller, Joan H⋅Singh, Navneet⋅Singh, Navneet⋅Spigel, David R⋅Spigel, David R⋅Stabler, Janis O⋅Stabler, Janis O⋅Tashbar, Joan⋅Tashbar, Joan⋅Masters, Gregory and Masters, GregoryJournal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 38, (no. 14), pp. 1632, 2020-May-10.
| Journal Article
Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO and OH (CCO) Joint Guideline Update Summary
Hanna, Nasser H⋅Temin, Sarah and Masters, Gregory
JCO oncology practice, pp. JOP1900770, 2020-Feb-24. | Journal Article
Therapy for Stage IV Non–Small-Cell Lung Cancer Without Driver Alterations: ASCO and OH (CCO) Joint Guideline Update Summary
Hanna, Nasser H⋅Temin, Sarah and Masters, Gregory
JCO Oncology Practice, pp. JOP1900770, 2020-02-24. | Journal Article
The Story of Angiogenesis Inhibitors in Non–small-cell Lung Cancer: The Past, Present, and Future
Shukla, Nikhil Atul⋅Yan, Melissa Noela and Hanna, Nasser
Clinical Lung Cancer, 2020-Mar-12. | Journal Article
2019
Acceptance and Commitment Therapy for Symptom Interference in Advanced Lung Cancer and Caregiver Distress: A Pilot Randomized TrialMosher, Catherine E⋅Mosher, Catherine E⋅Mosher, Catherine E⋅Mosher, Catherine E⋅Mosher, Catherine E⋅Mosher, Catherine E⋅Mosher, Catherine E⋅Mosher, Catherine E⋅Secinti, Ekin⋅Secinti, Ekin⋅Secinti, Ekin⋅Secinti, Ekin⋅Secinti, Ekin⋅Secinti, Ekin⋅Secinti, Ekin⋅Secinti, Ekin⋅Hirsh, Adam T⋅Hirsh, Adam T⋅Hirsh, Adam T⋅Hirsh, Adam T⋅Hirsh, Adam T⋅Hirsh, Adam T⋅Hirsh, Adam T⋅Hirsh, Adam T⋅Hanna, Nasser⋅Hanna, Nasser⋅Hanna, Nasser⋅Hanna, Nasser⋅Hanna, Nasser⋅Hanna, Nasser⋅Hanna, Nasser⋅Hanna, Nasser⋅Einhorn, Lawrence H⋅Einhorn, Lawrence H⋅Einhorn, Lawrence H⋅Einhorn, Lawrence H⋅Einhorn, Lawrence H⋅Einhorn, Lawrence H⋅Einhorn, Lawrence H⋅Einhorn, Lawrence H⋅Jalal, Shadia I⋅Jalal, Shadia I⋅Jalal, Shadia I⋅Jalal, Shadia I⋅Jalal, Shadia I⋅Jalal, Shadia I⋅Jalal, Shadia I⋅Jalal, Shadia I⋅Durm, Gregory⋅Durm, Gregory⋅Durm, Gregory⋅Durm, Gregory⋅Durm, Gregory⋅Durm, Gregory⋅Durm, Gregory⋅Durm, Gregory⋅Champion, Victoria L⋅Champion, Victoria L⋅Champion, Victoria L⋅Champion, Victoria L⋅Champion, Victoria L⋅Champion, Victoria L⋅Champion, Victoria L⋅Champion, Victoria L⋅Johns, Shelley A⋅Johns, Shelley A⋅Johns, Shelley A⋅Johns, Shelley A⋅Johns, Shelley A⋅Johns, Shelley A⋅Johns, Shelley A and Johns, Shelley AJournal of Pain and Symptom Management, vol. 58, (no. 4), Oct 2019.
| Journal Article
Clinical course of patients with cisplatin (CDDP)-associated neuropathy compared to other neurotoxic chemotherapyAlbany, Costantine⋅Albany, Costantine⋅Dockter, Travis⋅Dockter, Travis⋅Wolfe, Eric G⋅Wolfe, Eric G⋅Pachman, Deirdre R⋅Pachman, Deirdre R⋅Wagner-Johnston, Nina D⋅Wagner-Johnston, Nina D⋅Lazzara, Kayla Marie⋅Lazzara, Kayla Marie⋅Sego, Lina M⋅Sego, Lina M⋅Edwards, Sara I⋅Edwards, Sara I⋅Snow, Christin I⋅Snow, Christin I⋅Hanna, Nasser⋅Hanna, Nasser⋅Einhorn, Lawrence⋅Einhorn, Lawrence⋅Loprinzi, Charles L⋅Loprinzi, Charles L⋅Costello, Brian Addis and Costello, Brian AddisJournal of Clinical Oncology, vol. 37, (no. 15_suppl), pp. e23078, 2019-05-20.
| Journal Article
Crowdfunding for lung cancer costs
Nguyen, Ryan⋅Hanna, Nasser H and Vater, Laura
Journal of Clinical Oncology, vol. 37, (no. 15_suppl), pp. e18340, 2019-05-20. | Journal Article
Impact of smoke-free ordinance strength on smoking prevalence and lung cancer incidenceNguyen, Ryan⋅Nguyen, Ryan⋅Nguyen, Ryan⋅Nguyen, Ryan⋅Nguyen, Ryan⋅Nguyen, Ryan⋅Nguyen, Ryan⋅Vater, Laura⋅Vater, Laura⋅Vater, Laura⋅Vater, Laura⋅Vater, Laura⋅Vater, Laura⋅Vater, Laura⋅Timsina, Lava R⋅Timsina, Lava R⋅Timsina, Lava R⋅Timsina, Lava R⋅Timsina, Lava R⋅Timsina, Lava R⋅Timsina, Lava R⋅Durm, Greg Andrew⋅Durm, Greg Andrew⋅Durm, Greg Andrew⋅Durm, Greg Andrew⋅Durm, Greg Andrew⋅Durm, Greg Andrew⋅Durm, Greg Andrew⋅Rupp, Katelin⋅Rupp, Katelin⋅Rupp, Katelin⋅Rupp, Katelin⋅Rupp, Katelin⋅Rupp, Katelin⋅Rupp, Katelin⋅Wright, Keylee⋅Wright, Keylee⋅Wright, Keylee⋅Wright, Keylee⋅Wright, Keylee⋅Wright, Keylee⋅Wright, Keylee⋅Spitznagle, Miranda⋅Spitznagle, Miranda⋅Spitznagle, Miranda⋅Spitznagle, Miranda⋅Spitznagle, Miranda⋅Spitznagle, Miranda⋅Spitznagle, Miranda⋅Paul, Brandy⋅Paul, Brandy⋅Paul, Brandy⋅Paul, Brandy⋅Paul, Brandy⋅Paul, Brandy⋅Paul, Brandy⋅Jalal, Shadia Ibrahim⋅Jalal, Shadia Ibrahim⋅Jalal, Shadia Ibrahim⋅Jalal, Shadia Ibrahim⋅Jalal, Shadia Ibrahim⋅Jalal, Shadia Ibrahim⋅Jalal, Shadia Ibrahim⋅Carter-Harris, Lisa⋅Carter-Harris, Lisa⋅Carter-Harris, Lisa⋅Carter-Harris, Lisa⋅Carter-Harris, Lisa⋅Carter-Harris, Lisa⋅Carter-Harris, Lisa⋅Hudmon, Karen S⋅Hudmon, Karen S⋅Hudmon, Karen S⋅Hudmon, Karen S⋅Hudmon, Karen S⋅Hudmon, Karen S⋅Hudmon, Karen S⋅Hanna, Nasser H⋅Hanna, Nasser H⋅Hanna, Nasser H⋅Hanna, Nasser H⋅Hanna, Nasser H⋅Hanna, Nasser H⋅Hanna, Nasser H⋅Loehrer, Patrick J⋅Loehrer, Patrick J⋅Loehrer, Patrick J⋅Loehrer, Patrick J⋅Loehrer, Patrick J⋅Loehrer, Patrick J⋅Loehrer, Patrick J⋅Ceppa, DuyKhanh⋅Ceppa, DuyKhanh⋅Ceppa, DuyKhanh⋅Ceppa, DuyKhanh⋅Ceppa, DuyKhanh⋅Ceppa, DuyKhanh and Ceppa, DuyKhanhJournal of Clinical Oncology, vol. 37, (no. 15_suppl), pp. 6578, 2019-05-20.
| Journal Article
Interim safety analysis of consolidation nivolumab and ipilimumab versus nivolumab alone following concurrent chemoradiation for unresectable stage IIIA/IIIB NSCLC: Big Ten Cancer Research Consortium LUN 16-081Yan, Melissa⋅Yan, Melissa⋅Durm, Greg Andrew⋅Durm, Greg Andrew⋅Mamdani, Hirva⋅Mamdani, Hirva⋅Ganti, Apar Kishor⋅Ganti, Apar Kishor⋅Hrinczenko, Borys⋅Hrinczenko, Borys⋅Jabbour, Salma K⋅Jabbour, Salma K⋅Feldman, Lawrence Eric⋅Feldman, Lawrence Eric⋅Kloecker, Goetz H⋅Kloecker, Goetz H⋅Leal, Ticiana⋅Leal, Ticiana⋅Almokadem, Salah⋅Almokadem, Salah⋅Naidoo, Jarushka⋅Naidoo, Jarushka⋅Fujioka, Naomi⋅Fujioka, Naomi⋅Hanna, Nasser H and Hanna, Nasser HJournal of Clinical Oncology, vol. 37, (no. 15_suppl), pp. 8535, 2019-05-20.
| Journal Article
Predicting progression of in situ carcinoma in the era of precision genomicsCheng, Monica⋅Cheng, Monica⋅Cheng, Monica⋅Cheng, Monica⋅Hanna, Nasser H⋅Hanna, Nasser H⋅Hanna, Nasser H⋅Hanna, Nasser H⋅Davidson, Darrell D⋅Davidson, Darrell D⋅Davidson, Darrell D⋅Davidson, Darrell D⋅Gunderman, Richard B⋅Gunderman, Richard B⋅Gunderman, Richard B and Gunderman, Richard BJournal of thoracic disease, vol. 11, (no. 6), pp. 2225, 2019-Jun.
| Journal Article
